Precipitated by rapid advances in molecular diagnostic methods, from chromosomal microarray to whole exome sequencing, routine clinical genetic testing is now recommended for the etiological evaluation of all children with new diagnoses of global developmental delay, intellectual disability (ID), or autism spectrum disorder (ASD) [
1‐
4]. This surge in genetic testing has facilitated the identification of pathogenic rare genetic variants and, with the ascertainment of subgroups of individuals with shared variants, the identification of clinically meaningful genetic syndromes [
5]. To date, detailed developmental and behavioral characterization of these syndromes has lagged behind the genetic diagnoses, leaving considerable uncertainty regarding developmental trajectories, prognosis, and recommended treatment options for these disorders, despite having a molecular diagnosis. Interventions remain broad in focus, targeting the neurodevelopmental diagnoses (such as ASD or ID) rather than specific features of cognition or social communication that may define a particular molecularly defined syndrome. This considerable dissociation between the precision of genetic testing and the imprecision of clinical treatment may be addressable and represents a critical challenge in neurodevelopmental disorders. Improved and precise behavioral characterization of genetic syndromes associated with ID and ASD can inform not only prognosis but also treatment, with the ultimate goal of facilitating the discovery of targeted, mechanism-based interventions that may improve individual outcomes.
One of the most common chromosomal abnormalities associated with ASD and ID is the duplication of chromosome 15q11.2-q13.1 (Dup15q syndrome). This region includes the imprinted Prader-Willi/Angelman syndrome critical region (PWACR) as well as several genes critical for brain development and synaptic function, such as ubiquitin protein ligase E3A (
UBE3A), small nuclear ribonucleoprotein polypeptide N (
SNRPN), and three GABA
A receptor genes (
GABRB3,
GABRA5, and
GABRG3). Dup15q syndrome includes two primary types of duplications of 15q11.2-13.1: (1) an isodicentric chromosome 15 (idic(15)) that results in two additional maternally derived copies on a supernumerary chromosome that includes 15p and the proximal region of 15q11, most commonly leading to four copies of the region, or (2) an interstitial 15q duplication in which one extra copy of the 15q11.2-q13.1 region occurs on the same chromosome arm, typically resulting in three copies of the region, and has an overall milder phenotype [
6‐
9].
Neurodevelopmental characteristics of Dup15q syndrome
Systematic genetic screening in large cohorts of patients with ASD has revealed a high prevalence of Dup15q syndrome, with rates of 0.25–3 % depending on sample ascertainment [
10‐
14]. The neurodevelopmental “syndrome” of idic(15) has been characterized by a constellation of clinical features including mild to profound ID, central hypotonia resulting in motor delays, mild to profound language impairment, and impairments in social communication [
6,
15‐
26]. Although exhibiting a typically milder clinical phenotype, interstitial Dup15q also has been associated with ASD, hypotonia, and moderate ID to no general cognitive impairment [
27]. Epilepsy often develops early in infancy, with rates of 63 % in idic(15) and 16 % in interstitial duplications [
28,
29]. Considerable heterogeneity exists in neurodevelopmental outcomes, which may reflect whether they are interstitial or supernumerary, rare cases of more than expected duplication (e.g., interstitial duplication vs. rare interstitial triplication), additional rare or common genetic variation, timing and severity of epilepsy, or other unidentified factors [
18,
26]. Although children with idic(15) demonstrate more cognitive and behavioral impairment than those with interstitial duplications, no studies have directly compared these groups with regard to development and behavior.
Most of the clinical insights gained into Dup15q syndrome have resulted from retrospective chart reviews (e.g., [
25]) or case series of individual patients (e.g., [
30]) and, therefore, have mostly focused on categorical diagnoses and general descriptions of developmental domains. In the largest retrospective study of patients with Dup15q syndrome, Al Ageeli and colleagues [
25] reviewed 30 cases (50 % of each duplication type) and found that 77 % met the criteria for developmental delay, while 74 % had a diagnosis of ASD.
The only prospective study of children with Dup15q syndrome focused on a cohort of children with interstitial 15q11.2-q13.1 duplications. The investigators performed standardized diagnostic testing for ASD (using the Autism Diagnostic Observation Schedule (ADOS)) in order to identify genotype-phenotype relationships, and they found that 9/9 maternally derived duplications met criteria for ASD or autism and 2/4 paternally derived duplications met criteria for ASD or autism [
27].
Several questions remain unanswered in the developmental and behavioral characterization of children with 15q11.2-q13.1 duplications. First, while a large proportion of children with Dup15q syndrome meet the diagnostic criteria for ASD, are there distinctive behavioral and developmental features in this cohort that are not captured by a categorical diagnosis, particularly in the domain of social communication and adaptive function? Second, is there variability within the social communication and adaptive function of this cohort and, if so, does it relate to the duplication type or epilepsy status? To begin to address these questions, we examined the social communication, adaptive and cognitive skills in a clinic-referred sample of children with Dup15q syndrome of both duplication types. In order to identify distinctive developmental and behavioral features, we compared characteristics of children with Dup15q syndrome to a chronological age- and mental age-matched cohort of children with non-syndromic ASD. We then examined the variability in behavior and development within the Dup15q group by comparing children by duplication type and by presence of epilepsy.
Based on data from the case reports described earlier, we hypothesized that we would identify a distinct developmental profile in children with Dup15q syndrome defined by expressive language and motor impairment with relatively stronger social communication skills compared to a non-syndromic ASD comparison group, but that there would be considerable heterogeneity in function based largely on duplication type and presence of epilepsy.